KCM
MRTX

Knoll Capital Management’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Knoll Capital Management’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-5,000
Closed -$349K – 38
2022
Q3 		$349K Hold
5,000
– – 0.2% 27
2022
Q2 		$336K Hold
5,000
– – 0.19% 33
2022
Q1 		$411K Buy
+5,000
New +$411K 0.26% 33